10 Best Paper Stocks To Watch For 2016

When Warren Buffett dissolved his investment partnership in 1969 to focus on Berkshire Hathaway, the company he had acquired a few years earlier, he recommended that his clients invest in the Sequoia Fund (SEQUX). It was great advicefor more than three decades, anyway.

See Also: 5 Good Places to Put Your Money During a Bear Market

When I recommended five low-risk funds to Kiplinger readers in August 2011, Sequoia topped my list. Over the previous 10 years through August 31 of that year, the fund had returned an annualized 5.7%, an average of 3.0 percentage points per year better than Standard & Poors 500-stock index. Yet the fund was 18% less volatile than the index over that stretch. Wow!

Whats more, because asset bloat can cripple performance, the fund displayed an admirable willingness to limit growth. Sequoia closed to new investors from 1982 until 2008, and again in 2013.

10 Best Paper Stocks To Watch For 2016: RXI Pharmaceuticals Corporation(RXII)

 

RXi Pharmaceuticals Corporation, a biotechnology company, focuses on discovering and developing therapies primarily in the areas of dermatology and ophthalmology. The company develops therapies based on siRNA technology and immunotherapy agents. Its clinical development programs include RXI-109, a self-delivering RNAi compound, which is in Phase IIa clinical trial that is used to prevent or reduce dermal scarring following surgery or trauma, as well as for the management of hypertrophic scars and keloids; and Samcyprone, an immunomodulation agent, which is in Phase IIa clinical trial for the treatment of various disorders, such as alopecia areata, warts, and cutaneous metastases of melanoma. The companys preclinical program includes the development of products for ocular indications with RXI-109, including retinal and corneal scarring. Its discovery stage development programs include a dermatology franchise for the discovery of collagenase and tyrosinase targets for its RNAi platform; and ophthalmology franchise, a program for the discovery of sd-rxRNA compounds for oncology indications, including retinoblastoma. The company was incorporated in 2011 and is headquartered in Marlborough, Massachusetts.

Advisors’ Opinion:

  • [By Monica Gerson]

    RXi Pharmaceuticals Corp (NASDAQ: RXII) is expected to post a quarterly loss at $0.05 per share.

    InterOil Corporation (USA) (NYSE: IOC) is estimated to report a quarterly loss at $0.25 per share on revenue of $1.10 million.

10 Best Paper Stocks To Watch For 2016: Markel Corporation(MKL)

 

Markel Corporation markets and underwrites specialty insurance products in the United States and internationally. It operates through three segments: U.S. Insurance, International Insurance, and Reinsurance. The U.S. Insurance segment writes general liability, professional liability, property, personal line, program, workers’ compensation, and other insurance product lines. The International Insurance segment provides professional liability, marine and energy, general liability, property, and other insurance product lines, such as accident and health coverage insurance. The Reinsurance segment offers various treaty reinsurance products, such as property, casualty, auto, and others. Markel Corporation was founded in 1930 and is headquartered in Glen Allen, Virginia.

Advisors’ Opinion:

  • [By Michael Hooper]

    When compared with similar companies, Berkshire Hathaway carries a premium over Markel (NYSE: MKL  ) , valued at 1.15 times book value and a 20 forward P/E ratio; and Leucadia National (NYSE: LUK  ) , valued at 1.10 times book value and a 7.16 trailing P/E.

Top 5 Services Stocks To Buy Right Now: Clarke(t)

T.Clarke plc, a building services contractor, provides electrical and mechanical installation services and supplies associated equipment. The company offers information communications technology (ICT) services in the areas of structured cabling and connectivity, network infrastructure and security, networked energy management, data centre infrastructure, and managed and support services; facilities management services, such as preventative, reactive, and planned maintenance solutions; and green technologies services, which comprise photovoltaics, rainwater harvesting, biomass boilers, ground source heating, air source heating, wind turbines, lighting, and carbon reduction audit services. It also provides massive reading station redevelopment, cross rail, border rail link, and underground power upgrade services for the rail sector; lifecycle building services combining mechanical and electrical works with ICT for utilities and technologies sectors; lifecycle services for ho tel and residential sectors, which include electrical, ICT, and mechanical systems design, installation, commissioning, and maintenance; and mechanical and electrical contracting services for education, healthcare, government/local authority, retail and leisure, stadiums, transport, towers, media, and residential sectors. In addition, the company manufactures and prefabricates elements of an installation, as well as engineering components. T.Clarke plc was founded in 1889 and is headquartered in London, the United Kingdom.

Advisors’ Opinion:

  • [By Matthew Smith]

    The news we found most interesting yesterday was the story regarding AT&T (T) that broke during the session that they were looking to offload their tower assets. The deal could fetch as much as $5 billion and many are looking at this as a precursor to a much larger deal where AT&T would look to expand overseas via a large acquisition.

10 Best Paper Stocks To Watch For 2016: Freshpet, Inc.(FRPT)

Freshpet, Inc., incorporated on November 12, 2004, is a manufacturer of fresh, refrigerated pet food distributed across North America. The Company operates in the segment of manufacturing, marketing and distribution of pet food and pet treats for dogs and cats. The Company offers products consisting of dog food, cat food, and dog and cat treats. Its recipes include real, fresh meat and varying combinations of vegetables, leafy greens and anti-oxidant rich fruits, without the use of preservatives, additives or artificial ingredients. All of its products are sold under the Freshpet brand name, with ingredients, packaging and labeling customized by class of retail. It also offers fresh treats across all classes of retail under the Dognation and Dog Joy labels. The Company’s products are available in various forms, including slice and serve rolls, bagged meals and tubs.

All of the Company’s products are manufactured in the United States. The Company owns and opera tes refrigerated pet food manufacturing facility in North America, the Freshpet Kitchens at Bethlehem, Pennsylvania. The Company’s products are distributed throughout the United States and Canada into retail classes, including Grocery and Mass (which includes club), as well as Pet specialty and Natural retail. It sells its products through a network of company-owned branded refrigerators, the Freshpet Fridges. The Company designs, produces, installs and maintains the Freshpet Fridge through a combination of in-house resources and partners.

The Company competes with Mars, Nestle, The J.M. Smucker Company, Colgate-Palmolive and Blue Buffalo.

Advisors’ Opinion:

  • [By Lisa Levin]

    Freshpet Inc (NASDAQ: FRPT) shares shot up 25 percent to $10.36. Freshpet reported a Q2 loss of $0.10 per share on revenue of $33 million.

    Shares of Lantheus Holdings Inc (NASDAQ: LNTH) got a boost, shooting up 50 percent to $5.84 as the company reported strong Q2 results.

10 Best Paper Stocks To Watch For 2016: Xylem Inc.(XYL)

 

Xylem Inc. engages in the design, manufacture, and application of engineered technologies for the water and wastewater applications. It operates through two segments, Water Infrastructure and Applied Water. The Water Infrastructure segment offers various products, including water and wastewater pumps, treatment and testing equipment, and controls and systems, as well as filtration, disinfection, and biological treatment equipment under the Flygt, WEDECO, Godwin, WTW, Sanitaire, YSI, and Leopold names for the transportation, treatment, and testing of water and wastewater for public utilities and industrial applications. The Applied Water segment provides pumps, valves, heat exchangers, controls, and dispensing equipment systems under the Goulds Water Technology, Bell & Gossett, A-C Fire Pump, Standard Xchange, Lowara, Jabsco, Flojet, and Flowtronex names for residential and commercial building services, industrial water, and ir rigation applications. The company markets and sells its products through a network of direct sales force, resellers, distributors, and value-added solution providers in the United States, Europe, the Asia Pacific, and internationally. Xylem Inc. is headquartered in Rye Brook, New York.

Advisors’ Opinion:

  • [By Ben Levisohn]

    Flexing the barbell strategy to balance Safe Havens with more cyclical exposures. In our view, industrials investors should be positioning their portfolio with a barbell strategy, with half of the exposure in Safe Havens like General Electric, Xylem (XYL), Danaher, Honeywell International, Roper Technologies (ROP), and AMETEK (AME), and the other half selectively in the cyclical names that are better positioned today, such as Pentair, HD Supply Holdings (HDS),Actuant (ATU), Atkore International Group (ATKR), Ingersoll-Rand, and Eaton (ETN). We still believe risk-reward is mostly balanced and that the macro will remain choppy into 2017, supporting a positioning in the defensive names. But if investor sentiment improves on not-worse news and earnings results, the more cyclical names could fare better.

  • [By Ben Levisohn]

    Technology and Industrials are our favorite ways to buy cyclical MO. Specifically, we see the Technology Select Sector SPDR ETF (XLK) as an attractive pre-breakout idea and a likely candidate to lead the S&Ps secular advance over the coming years. Buy ideas at the stock level include: Accenture (ACN), Broadcom (AVGO), Microsoft , Texas Instruments (TXN),Visa (V),Yahoo! (YHOO). We also recommend buying the Industrial Select Sector SPDR ETF (XLI) which is reversing its year-long downtrend and in position for new highs over the coming months, in our view. Buy ideas at the stock level include: Honeywell International, Ingersoll-Rand (IR), Illinois Tool Works (ITW), 3M, Southwest Airlines (LUV), Xylem (XYL). Underlined stocks are fundamentally-rated Outperform at Oppenheimer.

10 Best Paper Stocks To Watch For 2016: Sony Corp Ord(SNE)

Sony Corporation designs, develops, manufactures, and sells electronic equipment, instruments, and devices for consumer, professional, and industrial markets worldwide. The company offers consumer products and devices, including televisions, video cameras, compact digital cameras and interchangeable single-lens cameras, Blu-ray Disc players/recorders, DVD-video players/recorders, home theaters and audio systems, and portable audio and car audio products. It also provides charged coupled devices, complementary metal-oxide semiconductor image sensors, system LSIs, small- and medium-sized LCD panels, and other semiconductors; and components, such as batteries, optical disk drives, chemical products, audio/video/data recording media, storage media, and optical pickups. In addition, the company develops, produces, markets, and distributes games, such as PlayStation3, PlayStation Portable, and PlayStation 2 hardware and related software; and PCs and flash memory digital audio pl ayers, as well as manufactures broadcast- and professional-use products, Blu-ray discs, DVDs, and CD discs. Further, it produces and distributes motion pictures and television programs, and home entertainment; creates and distributes digital content; operates television networks and studio facilities; and develops entertainment products, services, and technologies. Additionally, the company engages in the music publishing business, as well as provision of various financial services, including insurance, savings products, loans, and credit financing services; and a network service business and an advertising agency business. It also involves in research, development, design, production, marketing, sales, distribution, and servicing mobile phones, accessories, services, and applications. The company was formerly known as Tokyo Tsushin Kogyo Kabushiki Kaisha and changed its name to Sony Corporation in 1958. Sony Corporation was founded in 1946 and is based in Tokyo, Japan.

Advisors’ Opinion:

  • [By Demitrios Kalogeropoulos]

    Don’t write offNintendo’s (NASDAQOTH: NTDOY  ) chances for a strong holiday season just yet. Yes, even with a year’s head start, the company’s next-generation Wii U has been badly trailing sales of current-gen consoles from Microsoft (NASDAQ: MSFT  ) andSony (NYSE: SNE  ) . But that could be set to change soon.

  • [By Brian Stelter]

    Other companies, including Dish Network (DISH) and Sony (SNE), are already selling a cable-like bundle of channels via the Internet, but the prospect of Apple has garnered an outsized amount of attention.

  • [By Manikandan Raman]

    The Lazarus group has also been linked to the 2014 hack against Sony Corp (ADR) (NYSE: SNE).

    However, the Philippines central bank’s deputy governor, Nestor Espenilla, had said “no bank in the country had lost money to hackers, although he did not rule out the possibility of cyber attacks,” Reuters reported.

10 Best Paper Stocks To Watch For 2016: Progenics Pharmaceuticals Inc.(PGNX)

Progenics Pharmaceuticals, Inc., incorporated on December 1, 1986, is engaged in developing medicines and other products for targeting and treating cancer. The Company’s products in development include therapeutic agents designed to target cancer and imaging agents, which focuses on enabling clinicians and patients to accurately visualize and manage their diseases. The Company’s EXINI Bone BSI is an analytical tool that employs an artificial intelligence-based approach to apply techniques of statistical analysis and pattern recognition to quantify the information produced by bone scintigraphy (bone scan) images used to view cancer present in the skeleton. The EXINI Bone BSI tool reads bone scans and produces a standard, automated Bone Scan Index quantification. The Company’s clinical-stage products include AZEDRA, 1404 (trofolastat), PyL ((18F) DCFPyL), 1095 and PSMA ADC. The Company’s partnered products include Relistor- Subcutaneous injection, Relistor- Oral Tablets and PRO 140.

Azedra

Azedra is a radiotherapeutic product candidate in development as a treatment for malignant and/or recurrent pheochromocytoma and paraganglioma, rare tumors found in the adrenal glands and outside of the adrenal glands. The Company has completed enrollment in pivotal Phase IIb clinical trial under Special Protocol Assessment (SPA).

1404 (trofolastat)

The Company’s 1404 (trofolastat) is a technetium-99m labeled small molecule, which binds prostate specific membrane antigen (PSMA) and is used as an imaging agent to diagnose and detect localized prostate cancer, as well as soft tissue and bone metastases. The Company has completed a global multi-centered Phase II study assessing the diagnostic accuracy of 1404 imaging in men with high-risk prostate cancer and initiated a multi-center, open-label Phase III trial to determine the sensitivity and specificity of 1404 to correctly identify whether or not patients hav e clinically prostate cancer

PyL ((18F) DCFPyL)!

The Company’s PyL is a clinical-stage, fluorinated PSMA-targeted Positron Emission Topography (PET) imaging agent for prostate cancer that was discovered and developed at the Center for Translational Molecular Imaging at the Johns Hopkins University School of Medicine. The Company’s studies show the uptake of PyL is high in sites of putative metastatic lesions and primary tumors, suggesting the potential for high sensitivity in detecting prostate cancer.

1095

The Company’s 1095 is a PSMA-targeted Iodine-131 labeled small radiopharmaceutical molecule, which is designed to deliver a dose of radiation directly to prostate cancer cells with minimal impact on the surrounding healthy tissues. The Company focuses on initiating a Phase I clinical study.

PSMA ADC

PSMA ADC is a human monoclonal antibody-drug conjugate designed to deliver a chemotherapeutic agent to cancer. The Company’s Phase II, multicenter clinical tr ial to assess the safety, tolerability and anti-tumor activity of PSMA ADC, has been completed in both the chemotherapy refractory and chemotherapy naive patients with metastatic castration-resistant prostate cancer (mCRPC).

Relistor

The Company’s Relistor is used as a treatment for Opioid-Induced Constipation (OIC), which decreases the constipating side effects induced by opioid pain medications, such as morphine and codeine without diminishing their ability to relieve pain. Relistor-Subcutaneous injection is engaged in the treatment of OIC in patients with non-cancer pain, and is marketed in the United States. Relistor-Oral has completed Phase III clinical trials.

PRO 140

The Company’s PRO 140 is a humanized IgG4 monoclonal antibody directed against C-C chemokine receptor type 5 (CCR5), a molecular portal that human immunodeficiency virus (HIV) uses to enter T-cells. PRO 140 blocks the predominant HIV subtype (R5) entry i nto T-cells by masking this required co-receptor, CCR5. PRO ! 140 has b! een the subject of over seven clinical trials, each demonstrating efficacy by significantly reducing or controlling HIV viral load in human test subjects.

The Company competes with Merck & Co., Inc., Sucampo Pharmaceuticals, Inc., Shionogi & Co., Theravance, Inc., Johnson & Johnson, Medivation, Inc., Bayer HealthCare Pharmaceuticals Inc. and Aytu Bioscience Inc.

Advisors’ Opinion:

  • [By Lisa Levin]

    Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) shares shot up 29 percent to $6.37 after announcing the FDA approval of RELISTOR tablets for the treatment of opioid-induced constipation in adults with chronic non-cancer pain.

  • [By Ben Levisohn]

    After meeting with the senior management team of Progenics (PGNX) , Valeant’s partner for oral Relistor, we continue to think that this drug would be a good addition to Valeant’s GI (gastrointestinal) franchise. The PDUFA date for oral Relistor is 7/19/16. AlthoughValeant is leading interactions with the FDA, Progenics is highly confident regarding an approval in July based on its discussions with Valeant. Progenics believes that oral Relistor could be a $1B+ opportunity for Valeant, even with the recent decrease in opioid usage. For context, we estimate ’16 sales of $9.9B for Valeant. An approval for oral Relistor would also help remind the Street that Valeant’s brand drug pipeline is underappreciated, in our view. We think pipeline advancements for brand drugs could drive multiple expansion forValeant shares (on P/E).

10 Best Paper Stocks To Watch For 2016: Marsh & McLennan Companies, Inc.(MMC)

 

Marsh & McLennan Companies, Inc., a professional services firm, provides advice and solutions in the areas of risk, strategy, and people worldwide. It operates through two segments, Risk and Insurance Services; and Consulting. The Risk and Insurance Services segment offers risk management services, such as risk advice, risk transfer, risk control, and mitigation solutions, as well as insurance, reinsurance broking, catastrophe and financial modeling services, and related advisory services. This segment serves businesses, public entities, insurance companies, associations, professional services organizations, and private clients. The Consulting segment provides health, retirement, talent, and investments consulting services and products; and specialized management, and economic and brand consulting services. This segment assists public and private sector employers in the design, management, and administration of employee health care programs; provides a range of strategic and compliance-related retirement services and solutions to corporate, governmental, and institutional clients; advises organizations on the engagement, management, and rewarding of employees; and offers investment consulting and other services to the sponsors of pension funds, foundations, endowments, other investors, and wealth management companies. Marsh & McLennan Companies, Inc. was founded in 1871 and is headquartered in New York, New York.

Advisors’ Opinion:

  • [By Reuters]

    Wendy Maeda/The Boston Globe via Getty Images NEW YORK — Walgreen is moving 120,000 employees to a private health insurance exchange from coverage provided directly from carriers, the company will announce Wednesday. The pharmacy chain will join 17 other large employers on the Aon Hewitt Corporate Health Exchange as part of a growing movement to offer employees fixed dollar amounts to purchase their own plans on such exchanges. The end-cost to employees depends on the plan chosen, but they typically get more options than under traditional arrangements. Private exchanges mimic the coverage mandated as part of the Affordable Care Act. Enrollment in the public exchanges starts Oct. 1. “What happens to employer contributions over time? Will they put in as much as they put in the past? These are unanswered questions but potential negatives,” says Paul Fronstin, a senior research associate with the Employee Benefit Research Institute. The benefit to Walgreen and other employers is unknown at this point, as their cost-savings aren’t clear. Of the 180,000 Walgreen (WAG) employees eligible for health care insurance, 120,000 opted for coverage for themselves and 40,000 family members. Another 60,000 employees, many of them working part-time, weren’t eligible for health insurance. Aon Hewitt (AON) says other participants in its program include retailer Sears Holding (SHLD) and Darden Restaurants (DRI). These new additions raise enrollment to 330,000 from 100,000 last year, and Aon Hewitt estimates enrollment will jump to 600,000 next year, a fivefold increase from 2012. By 2017, nearly 20 percent of employees nationwide could get their health insurance through a private exchange, according to Accenture Research (ACN). A recent report by the National Business Group on Health said that 30 percent of large employers are considering moving active employees to exchanges by 2015. Other major providers of private exchanges include Mercer, a division of Marsh & Mc

10 Best Paper Stocks To Watch For 2016: Medtronic plc(MDT)

 

Medtronic plc manufactures and sells device-based medical therapies worldwide. The companys Cardiac and Vascular Group segment offers pacemakers, implantable cardioverter defibrillators and cardiac resynchronization therapy devices, AF products, diagnostics and monitoring devices, and remote monitoring and patient-centered software; and heart valves, percutaneous coronary intervention stent products, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular intervention products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment provides gastrointestinal diagnostics, ablation, and interventional lung solutions; stapling, vessel sealing, and other surgical instruments; sutures; electrosurgery products; hernia mechanical devices; mesh implants; products for patient monitoring and recovery; sensors; monitors; compression and dialysis, enteral feeding, and wound care products; and operating room supplies, electrodes, needles, syringes, and sharps disposals. The companys Restorative Therapies Group segment offers products for various areas of the spine; bone graft substitutes; biologic products; trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis; products to treat conditions of the ear, nose, throat, and neurological disorders; systems that incorporate advanced energy surgical instruments; products for haemostatic sealing of soft tissue and bone; and image-guided surgery and intra-operative imaging systems. Its Diabetes Group segment provides insulin pumps and consumables; continuous glucose monitoring systems; and Web-based therapy management software solutions. It serves hospitals, physicians, clinicians, and patients. M edtronic plc was founded in 1949 and is headquartered in Dub! lin, Ireland.

Advisors’ Opinion:

  • [By Teresa Rivas]

    Medtronic (MDT) is higher Monday, helped by a bullish note from SunTrust Robinson Humphrey.

    Medtronic Micra pacemaker Medtronic/Associated Press

    Analyst Bruce Nudell and his team intitiated coverage of the stock with a Buy rating and $93 price target. Nudell writes that he likes Medtronics leadership position across major markets, and he believes it can sustain mid-single digit revenue growth, while also expanding margins and growing earnings.

    He also praises the companys robust free cash flow generation and its commitment to returning 50% or more of its cash to shareholders, and writes that the companys rich pipeline, opportunities in emerging markets and focus on economic value make it a compelling buy.

    More detail from the note:

    Medtronic is market leader across several medical device categories and well-positioned for healthy growth sustainably. While its significant exposure to large mature markets like spine, CRM, and stents will remain a drag, the pipeline is rich (target of 150-350bps annual growth contribution from new products), expansion into emerging markets (150-200bps of growth per year) as well as a keen focus on economic value yielding higher mix of services revenue (40-60bps of growth per year) makes us confident that mid-single digit revenue growth is sustainable.

    With integration of Covidien ongoing, operating profitability and realization of cost synergies will remain the key focal point for investors nearer term; FX has clouded visibility, though management insists that underlying op-ex gains are firmly on track. Our model assumes deal related operating profit gains on the order of $900mm by FY2018 consistent with recent company commentary that the initial $850M target has potential upside. MDT foresees continued op-margin expansion beyond FY 2018 largely through plant rationalization (down from the current 80) which could drive outer year margin performance beyond that which we mod

10 Best Paper Stocks To Watch For 2016: Norwegian Cruise Line Holdings Ltd.(NCLH)

 

Norwegian Cruise Line Holdings Ltd. operates as a cruise line company that offers various itineraries. It offers cruises ranging from 1 day to 180 days itineraries to approximately 510 destinations worldwide. The company offers its products through independent travel agents, wholesalers, and tour operators. It operates 22 ships under the Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises brands with approximately 45,000 Berths. The company was founded in 1966 and is headquartered in Miami, Florida.

Advisors’ Opinion:

  • [By Ben Levisohn]

    Shares of Carnival have dropped 4.2% to $43.74 at 2:39 p.m. today, while Royal Caribbean Cruise (RCL) has tumbled 5.6% to $66.15, and Norwegian Cruise Line Holdings (NCLH) is off 4.3% at $38.63.